renal cell cancer

Showing 1 - 25 of 56

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Urological Malignancies, Prostate Cancer, Renal Cell Cancer Trial in Seoul

Recruiting
  • Urological Malignancies
  • +4 more
    • Seoul, Korea, Republic of
      Yonsei Severance Hospital
    Jan 30, 2023

    Benign Kidney Tumor, Kidney Tumor, Renal Cell Cancer Trial in San Francisco (Hyperpolarized Carbon C 13 Pyruvate, Magnetic

    Recruiting
    • Benign Kidney Neoplasm
    • +2 more
    • Hyperpolarized Carbon C 13 Pyruvate
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Jan 6, 2023

    Triple Negative Breast Cancer, Renal Cell Cancer, High Grade Ovarian Serous Adenocarcinoma Trial in United Kingdom

    Recruiting
    • Triple Negative Breast Cancer
    • +3 more
    • Modi-1/Modi-1v
    • +2 more
    • Brighton, Default, United Kingdom
    • +13 more
    Nov 18, 2022

    Renal Cell Cancer, Melanoma, Non-Small-Cell Lung Cancer Trial in Duarte, Louisville, New York (PF-07263689, Sasanlimab)

    Active, not recruiting
    • Renal Cell Cancer
    • +9 more
    • PF-07263689
    • Sasanlimab
    • Duarte, California
    • +5 more
    Nov 8, 2022

    NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • +12 more
    • Tucson, Arizona
    • +26 more
    Aug 1, 2022

    Renal Cell Cancer Trial (Axitinib, Pembrolizumab)

    Withdrawn
    • Renal Cell Cancer
    • (no location specified)
    Jul 29, 2022

    Describe Kidney Cancer Patient Population Treatment, and Results

    Not yet recruiting
    • Renal Cell Cancer
    • +6 more
      • (no location specified)
      May 2, 2022

      Liver Metastases, Liver Metastasis Colon Cancer, Colorectal Cancer Trial in Tampa (DNX-2440)

      Recruiting
      • Liver Metastases
      • +10 more
      • DNX-2440
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute, Inc.
      Mar 28, 2022

      Fear of Cancer Recurrence in Genitourinary Cancer

      Recruiting
      • Fear of Cancer Recurrence
      • +4 more
      • FCR7 questionnaire
      • Munich, Bavaria, Germany
        Ludwig-Maximilian-Universität
      Apr 5, 2022

      Malignant Melanoma, NSCLC, Renal Cell Cancer Trial in United Kingdom (ImmuniCell®)

      Terminated
      • Malignant Melanoma
      • +2 more
      • ImmuniCell®
      • Cardiff, United Kingdom
      • +6 more
      Mar 8, 2022

      Renal Cell Cancer Trial in Japan, United Kingdom, United States (Avelumab (MSB0010718C), Axitinib (AG-013736))

      Completed
      • Renal Cell Cancer
      • Avelumab (MSB0010718C)
      • Axitinib (AG-013736)
      • Scottsdale, Arizona
      • +20 more
      Dec 6, 2021

      Renal Cell Cancer, Metastatic Castration Resistant Prostate Cancer Trial in Australia, Canada, United States (Ciforadenant,

      Completed
      • Renal Cell Cancer
      • Metastatic Castration Resistant Prostate Cancer
      • Tucson, Arizona
      • +19 more
      Aug 27, 2021

      Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma Trial in United States (Sacituzumab Govitecan-hziy (SG))

      Completed
      • Gastric Adenocarcinoma
      • +15 more
      • Sacituzumab Govitecan-hziy (SG)
      • Aurora, Colorado
      • +11 more
      Aug 10, 2021

      Renal Cell Cancer Trial in Cambridge (Olaparib, Cediranib, Durvalumab)

      Recruiting
      • Renal Cell Cancer
      • Cambridge, England, United Kingdom
        Addenbrooke's Hospital
      May 21, 2021

      (NIS) of Nivolumab With or Without Ipilimumab in Advanced Kidney

      Recruiting
      • Renal Cell Carcinoma
      • +5 more
        • Paris, France
        • +1 more
        Feb 23, 2021

        Renal Cell Carcinoma, Hereditary Leiomyomatosis, Renal Cell Cancer Trial run by the NCI (Vandetanib, Metformin,

        Terminated
        • Renal Cell Carcinoma
        • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Jan 12, 2021

        Renal Cell Cancer Trial in Seoul (Cabometyx)

        Not yet recruiting
        • Renal Cell Cancer
        • Seoul, Korea, Republic of
          Asan Medical Center
        Jan 15, 2021

        Kinase Inhibitors Based on Protein Phosphorylation Profiles in

        Terminated
        • Renal Cell Cancer
          • Amsterdam, Noord Holland, Netherlands
            VU Medical Center
          Nov 18, 2020

          Renal Cell Cancer, Prostate Cancer, Effects of Chemo Trial in Boston (CORA- Device:smartphones")

          Completed
          • Renal Cell Cancer
          • +2 more
          • CORA- Device:smartphones"
          • Boston, Massachusetts
            Partners HealthCare Connected Health
          Aug 29, 2020

          Renal Cell Carcinoma, Kidney Cancer, Adenocarcinoma of Kidney Trial (NanoDoce (sterile nanoparticulate docetaxel) Powder for

          Withdrawn
          • Renal Cell Carcinoma
          • +4 more
          • NanoDoce (sterile nanoparticulate docetaxel) Powder for Suspension
          • (no location specified)
          Jul 31, 2020

          NANOTECH RCC Biomarkers

          Completed
          • Renal Cell Carcinoma
          • Renal Cell Cancer
            • Saint Louis, Missouri
              Washington University St Louis School of Medicine
            May 5, 2020

            Diarrhea Caused by Drug (Disorder), Renal Cell Cancer Trial in Rome (Donor FMT, Sham FMT)

            Completed
            • Diarrhea Caused by Drug (Disorder)
            • Renal Cell Cancer
            • Donor FMT
            • Sham FMT
            • Rome, Italy
              Fondazione Policlinico Universitario "A. Gemelli" IRCCS
            Mar 15, 2020

            Prostate Cancer, Renal Cell Cancer, Bladder Cancer Trial in Seoul

            Recruiting
            • Prostate Cancer
            • +3 more
              • Seoul, Korea, Republic of
                Department of Urology, Urological Science Institute, Yonsei Univ
              Dec 10, 2019

              Metastatic Melanoma, Renal Cell Cancer Trial run by the NCI (aldesleukin)

              Completed
              • Metastatic Melanoma
              • Renal Cell Cancer
              • aldesleukin
              • Bethesda, Maryland
                National Institutes of Health Clinical Center, 9000 Rockville Pi
              Dec 11, 2019

              Muscle Energy Metabolism in RCC Patients Treated With Sunitinib

              Withdrawn
              • Renal Cell Cancer
              • Fatigue
                • Edmonton, Alberta, Canada
                  Cross Cancer Institute
                Jul 2, 2019